Hepatitis C Virus Ii. Infection and Disease

Description

• Written by top researchers who have lead this filed since the discovery of hepatitis C virus
• Provide a concise and current review of the state of this rapidly advancing field
• Strong focus on rapid advances in treating and managing hepatitis C infection  

This book helps scientists, clinicians and other interested individuals understand recent clinical advances and challenges for the future. It covers many basic aspects of the pathogenesis of chronic hepatitis C, HCV infections in particular populations, approaches to therapy, and prevention and control of HCV Infection. The book provides a succinct review of the large amount of data generated by multiple groups over the past two decades that has revealed the natural history of HCV infection. Similarly, it summarizes current understanding of the origins of HCV-associated hepatocellular carcinoma, cirrhosis and hepatic fibrosis. Extra-hepatic manifestation and metabolic disorders related to HCV infection are described. In this volume, these clinically important aspects of HCV infection are comprehensively described. Highlights are description of newly developed direct- acting antivirals. The authors represent a worldwide distribution of leaders in the field reflecting the global nature of HCV infection. Based on recent data concerning the genetic- and geographical diversity of HCV, and increased global disease burden of HCV infection, challenges for global control of HCV infections are described.

Tatsuo Miyamura M.D. PhD. (Jikei University, Japan)

Stanley M.Lemon M.D. PhD.(The University of North Carolina, USA) 

Christopher M. Walker PhD. (The Research Institute at Nationwide Children’s Hospital, USA)

Takaji Wakita M.D. PhD. (National Institute of Infectious Diseases, Japan)